Back to today’s briefing

Story perspectives

Inflammatix's TriVerity™ Test Wins FDA Approval for Fast Infection Detection

1/25/2025

41 5

Summary

Story summary

Inflammatix has achieved a significant milestone with FDA clearance for its groundbreaking TriVerity™ Test. This first-of-its-kind molecular blood test can swiftly identify bacterial and viral infections, helping determine the urgent care patients with suspected acute infections or sepsis need. The exciting announcement was made on January 21, 2025, in Sunnyvale, California.

1 of 1

Story summary

Inflammatix has achieved a significant milestone with FDA clearance for its groundbreaking TriVerity™ Test. This first-of-its-kind molecular blood test can swiftly identify bacterial and viral infections, helping determine the urgent care patients with suspected acute infections or sepsis need. The exciting announcement was made on January 21, 2025, in Sunnyvale, California.